Validation of shortened 2-day sterility testing of mesenchymal stem cell-based therapeutic preparation on an automated culture system

[1]  P. Kruzliak,et al.  Umbilical Cord Tissue-Derived Cells as Therapeutic Agents , 2015, Stem cells international.

[2]  P. Kruzliak,et al.  Can We Predict Clinical Cardiotoxicity with Cardiac Biomarkers in Patients After Haematopoietic Stem Cell Transplantation? , 2015, Cardiovascular Toxicology.

[3]  E. Wood,et al.  Bacterial safety of cell‐based therapeutic preparations, focusing on haematopoietic progenitor cells , 2014, Vox sanguinis.

[4]  Didier Hocquet,et al.  Validation of an automated blood culture system for sterility testing of cell therapy products. , 2014, Cytotherapy.

[5]  E. Flory,et al.  European Regulatory Tools for Advanced Therapy Medicinal Products , 2013, Transfusion Medicine and Hemotherapy.

[6]  R. Gupta,et al.  Evaluation of growth based rapid microbiological methods for sterility testing of vaccines and other biological products. , 2011, Vaccine.

[7]  T. Moccetti,et al.  A practical approach for the validation of sterility, endotoxin and potency testing of bone marrow mononucleated cells used in cardiac regeneration in compliance with good manufacturing practice , 2009, Journal of Translational Medicine.

[8]  P. Murray,et al.  Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR‐compliant method , 2006, Transfusion.

[9]  D. Kadidlo,et al.  Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  R. Kamble,et al.  Microbial contamination of hematopoietic progenitor cell grafts—incidence, clinical outcome, and cost‐effectiveness: an analysis of 735 grafts , 2005, Transfusion.

[11]  P. Murray,et al.  Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products. , 2004, Cytotherapy.

[12]  L. Smith,et al.  Bacterial Contamination of Blood Components , 2003, American Society for Clinical Laboratory Science.

[13]  H. Lazarus,et al.  Contamination during in vitro processing of bone marrow for transplantation: clinical significance. , 1991, Bone marrow transplantation.

[14]  A. Menasalvas,et al.  Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant , 2007, Bone Marrow Transplantation.

[15]  J. M. Fernández,et al.  Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation. , 2004, Haematologica.

[16]  J. Lowder,et al.  Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact. , 2003, Cytotherapy.